You are here

Is Starving Cancer the Key to New Therapies?

Researchers have identified a vital supply route for cancer cells

Researchers have identified a vital supply route that cancer cells use to obtain their nutrients—a discovery that could lead to new treatments to stop the growth of tumors.   The research team blocked gateways through which the cancer cell was obtaining the amino acid glutamine and found the cells almost completely stopped growing.

"This is likely to work in a wide range of cancers, because it is a very common mechanism in cancer cells," said lead researcher Professor Stefan Bröer from The Australian National University (ANU). "Better still, this should lead to chemotherapy with much less serious side effects, as normal cells do not use glutamine as a building material. Crucial white blood cells, which current treatments damage, could be spared, and it could cut out the hair loss that chemotherapy causes."   

There are 917 types of cancer currently identified, and many cures work only for a single type of the disease or become ineffective as cancers develop resistance to chemotherapy. However, Broer, a biochemist in the ANU Research School of Biology, said the new approach would be less prone to resistance because blocking the glutamine transport mechanism is an external process that would be hard for cancer cells to get around.

The team first attempted a glutamine blockade by genetically altering cancer cells to disable their main glutamine transporter. However, this was not very effective, Professor Bröer said. "It was not quite as simple as we thought. The cells set off a biochemical alarm, which opened a back door in the cell so they could still get the glutamine they needed," he said.

Once the team had disabled the second gateway by turning off the biochemical alarm with a technique known as RNA silencing, the cells' growth was reduced by 96%.

The results are published in the Journal of Biological Chemistry. Lead author Angelika Bröer spearheaded the effort to identify and genetically knock out glutamine transporters. "It is an exciting time to do cancer research,” she said. “We now have precision tools in our hands to manipulate the genome of cancer cells, allowing us to address problems that were difficult to solve previously."   

Now that the importance of glutamine gateways has been identified in cancer, the hunt is on to find drug treatments that will lock them down and kill the disease. "We have developed a set of tests which make it very easy to determine if a drug is targeting glutamine transporters," Angelika Broer said. "This means we can set robots to work that will test tens of thousands of drugs for us over the next year or two."  

Source: ANU; May 5, 2016.

More Headlines

Combination of Two Drugs Could Reduce Tumor Growth
First and Only Treatment Reduces Depressive Symptoms Within Days
Bone Marrow Cleared of Leukemia in Almost 60% of Patients
Atezolizumab in Combination with Chemotherapy is the Only First-line Cancer Immunotherapy for ES-SCLC
Pre-clinical Trials Showed Drug Inhibits Fibroblast Activity and Collagen Deposition
PARG Inhibitor Exploits Weakness, Kills Cells
Inexpensive, Wearable Therapy Increases Arm Mobility, Reduces Stiffness
National Statistics Report Factors In Race, Ethnicity for the First Time